Replies to post #854 on Synaptogenix Inc (SNPX)

[SF Wolf]

Thanks for clarifying that F1ash.

I hope AVXL is as successful as I believe NTRP will be.

I also believe that NTRP will be the first company in the history of AD research to report a treatment that actually works. When it does it is going to become the industry leader and dominate news on AD research and cure.

The Trump administration has indicated it wants less oversight and more fast track approval of promising drugs and it just might turn out that with positive Phase 2b results Bryostatin will be an early candidate for some kind of new FDA expedited process.

The potential societal and fiscal benefits will likely bring pressure on the FDA to act.

Alzheimer’s is a major drain on Medicare, Medicaid, and Social Security Disability budgets, (not to mention long suffering families). A successful treatment will change the math on all of those programs and save the US taxpayer possibly trillions.